The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Aripiprazole Clonmel 5 mg tablets



Clonmel Healthcare LtdPA0126/266/001

Main Information

Trade NameAripiprazole Clonmel 5 mg tablets
Active SubstancesAripiprazole
Dosage FormTablet
Licence HolderClonmel Healthcare Ltd
Licence NumberPA0126/266/001

Group Information

ATC CodeN04BD Monoamine oxidase B inhibitors
N04BD02 rasagiline

Status

License statusAuthorised
Licence Issued17/07/2015
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable ListAripiprazole 5mg Tablets
Interchangeable List CodeIC0092-001-002
Interchangeable List DocumentPDF of Interchangeable List
« Back